Nonresolving inflammation - PubMed (original) (raw)
Review
. 2010 Mar 19;140(6):871-82.
doi: 10.1016/j.cell.2010.02.029.
Affiliations
- PMID: 20303877
- DOI: 10.1016/j.cell.2010.02.029
Free article
Review
Nonresolving inflammation
Carl Nathan et al. Cell. 2010.
Free article
Abstract
Nonresolving inflammation is a major driver of disease. Perpetuation of inflammation is an inherent risk because inflammation can damage tissue and necrosis can provoke inflammation. Nonetheless, multiple mechanisms normally ensure resolution. Cells like macrophages switch phenotypes, secreted molecules like reactive oxygen intermediates switch impact from pro- to anti-inflammatory, and additional mediators of resolution arise, including proteins, lipids, and gasses. Aside from persistence of initiating stimuli, nonresolution may result from deficiencies in these mechanisms when an inflammatory response begins either excessively or subnormally. This greatly complicates the development of anti-inflammatory therapies. The problem calls for conceptual, organizational, and statistical innovations.
2010 Elsevier Inc. All rights reserved.
Similar articles
- Anti-inflammatory lipid mediators and insights into the resolution of inflammation.
Lawrence T, Willoughby DA, Gilroy DW. Lawrence T, et al. Nat Rev Immunol. 2002 Oct;2(10):787-95. doi: 10.1038/nri915. Nat Rev Immunol. 2002. PMID: 12360216 Review. - Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics.
Serhan CN, Chiang N. Serhan CN, et al. Rheum Dis Clin North Am. 2004 Feb;30(1):69-95. doi: 10.1016/S0889-857X(03)00117-0. Rheum Dis Clin North Am. 2004. PMID: 15061569 Review. - New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases.
Yacoubian S, Serhan CN. Yacoubian S, et al. Nat Clin Pract Rheumatol. 2007 Oct;3(10):570-9; quiz 1 p following 589. doi: 10.1038/ncprheum0616. Nat Clin Pract Rheumatol. 2007. PMID: 17906612 Review. - Immune and inflammatory mechanisms in neuropathic pain.
Moalem G, Tracey DJ. Moalem G, et al. Brain Res Rev. 2006 Aug;51(2):240-64. doi: 10.1016/j.brainresrev.2005.11.004. Epub 2006 Jan 4. Brain Res Rev. 2006. PMID: 16388853 Review. - Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.
Sartor RB. Sartor RB. Gastroenterol Clin North Am. 1995 Sep;24(3):475-507. Gastroenterol Clin North Am. 1995. PMID: 8809232 Review.
Cited by
- Resolvin E1 regulates osteoclast fusion via DC-STAMP and NFATc1.
Zhu M, Van Dyke TE, Gyurko R. Zhu M, et al. FASEB J. 2013 Aug;27(8):3344-53. doi: 10.1096/fj.12-220228. Epub 2013 Apr 29. FASEB J. 2013. PMID: 23629863 Free PMC article. - Translational Nano-Medicines: Targeted Therapeutic Delivery for Cancer and Inflammatory Diseases.
Talekar M, Tran TH, Amiji M. Talekar M, et al. AAPS J. 2015 Jul;17(4):813-27. doi: 10.1208/s12248-015-9772-2. Epub 2015 Apr 29. AAPS J. 2015. PMID: 25921939 Free PMC article. Review. - Immune cell-mediated venous thrombus resolution.
Henke PK, Nicklas JM, Obi A. Henke PK, et al. Res Pract Thromb Haemost. 2023 Nov 20;7(8):102268. doi: 10.1016/j.rpth.2023.102268. eCollection 2023 Nov. Res Pract Thromb Haemost. 2023. PMID: 38193054 Free PMC article. Review. - Astragalin attenuates oxidative stress and acute inflammatory responses in carrageenan-induced paw edema in mice.
Alblihed MA. Alblihed MA. Mol Biol Rep. 2020 Sep;47(9):6611-6620. doi: 10.1007/s11033-020-05712-z. Epub 2020 Aug 8. Mol Biol Rep. 2020. PMID: 32770524 - Functions of interleukin-34 and its emerging association with rheumatoid arthritis.
Zhou RP, Wu XS, Xie YY, Dai BB, Hu W, Ge JF, Chen FH. Zhou RP, et al. Immunology. 2016 Dec;149(4):362-373. doi: 10.1111/imm.12660. Epub 2016 Sep 23. Immunology. 2016. PMID: 27550090 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources